• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Izumi Koji  泉 浩二

ORCIDConnect your ORCID iD *help
… Alternative Names

IZUMI Kouji  泉 浩二

Less
Researcher Number 80646787
Other IDs
External Links
Affiliation (Current) 2022: 金沢大学, 附属病院, 講師
Affiliation (based on the past Project Information) *help 2017 – 2022: 金沢大学, 附属病院, 講師
2018: 金沢大学, 附属病院, 特任助教
2013 – 2016: 金沢大学, 医学系, 助教
2013 – 2016: 金沢大学, 医学系, 特任助教
Review Section/Research Field
Principal Investigator
Urology / Basic Section 56030:Urology-related
Except Principal Investigator
Urology / Basic Section 56030:Urology-related / Medium-sized Section 56:Surgery related to the biological and sensory functions and related fields
Keywords
Principal Investigator
ケモカイン / 前立腺癌 / 腫瘍随伴性マクロファージ / 去勢抵抗性前立腺癌 / 転移 / マクロファージ / CCL2 / CCL17 / CCL22 / アンドロゲン受容体 … More / 腫瘍免疫 / 制御性T細胞 / 去勢抵抗性 / タキサン抵抗性 / コーヒー / ジテルペン / KRAS … More
Except Principal Investigator
前立腺癌 / 去勢抵抗性前立腺癌 / ケモカイン / アンドロゲン受容体 / クロストーク / 微小環境 / フラボノイド誘導体 / 腫瘍免疫 / 免疫チェックポイント / マイクロRNA / micro RNA / 去勢抵抗性 / 2’-hydroxyflavanone / 誘導体 / AR-V7 / 2'-hydroxyflavanone / DHEA / 男性不妊症 / ゲノム / Y染色体 / AZF / Alu配列 / SINE / バイオインフォマティクス / パリンドローム / bioinformatics / GEO / ribosome pathway / 造精機能低下 / ゲノム病 / Alu / BPY2 / SOD3 / 共培養 / 間質細胞 / アンドロゲン / アンドロゲン受容体 / アンドロゲン感受性前立腺癌細胞 / アンドロゲン非依存性前立腺癌細胞 / アンドロゲン生合成 / 癌微小環境 / 骨転移 / CRPC / ドセタキセル / カバジタキセル / 耐性 / ドセタキセル耐性 / カバジタキセル耐性 / 再燃メカニズム / 免疫チェックポイント分子 / シグナル伝達系 / NF-κB / 複合がん免疫療法 / 癌細胞間作用 / 抗癌剤耐性 / フラボノイド / 薬剤耐性 / タキサン耐性 / taxane系耐性前立腺癌 / Taxane系耐性前立腺癌 / エクソソーム / 遊走能 / 内臓転移 / リンパ節転移 / 腎細胞癌 / TCRレパトア / 免疫チェックポイント阻害薬 / バイオマーカー / 肝転移 / 肝間質細胞 / 間葉上皮移行 Less
  • Research Projects

    (16 results)
  • Research Products

    (32 results)
  • Co-Researchers

    (12 People)
  •  KRAS活性を介したダブルネガティブ去勢抵抗性前立腺癌進展機構の解明Principal Investigator

    • Principal Investigator
      泉 浩二
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kanazawa University
  •  ポストAR時代の治療戦略構築に向けたアンドロゲン非依存前立腺癌進展機構の解明

    • Principal Investigator
      溝上 敦
    • Project Period (FY)
      2021 – 2022
    • Research Category
      Grant-in-Aid for Challenging Research (Exploratory)
    • Review Section
      Medium-sized Section 56:Surgery related to the biological and sensory functions and related fields
    • Research Institution
      Kanazawa University
  •  腎細胞癌におけるIO薬効果予測因子の基礎的・臨床的探索

    • Principal Investigator
      角野 佳史
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kanazawa University
  •  Coffee diterpens inhibit prostate cancer progressionPrincipal Investigator

    • Principal Investigator
      IZUMI Kouji
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kanazawa University
  •  Androgen receptor signaling-controlled microRNA inhibits prostate cancer metastasis

    • Principal Investigator
      NOHARA Takahiro
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kanazawa University
  •  Progression of prostate cancer bone metastasis by exosomal micro RNA regulated-chemokine

    • Principal Investigator
      NARIMOTO Kazutaka
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      St. Luke's International University
  •  Development of combined immune-oncology therapy targeting immune checkpoint for castration-resistant prostate cancer

    • Principal Investigator
      KONAKA Hiroyuki
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kanazawa University
  •  The development of the innovative therapeutic drugs which targete crosstalk in the prostate cancer microenvironment

    • Principal Investigator
      MIZOKAMI Atsushi
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kanazawa University
  •  Mechanism of CRPC mediated by CCL2 during suppression of AR signaling

    • Principal Investigator
      NOHARA Takahiro
    • Project Period (FY)
      2017 – 2018
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Urology
    • Research Institution
      Kanazawa University
  •  Induction of immune tolerance via CCL20 during inhibition of androgen/AR signalingPrincipal Investigator

    • Principal Investigator
      IZUMI Kouji
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kanazawa University
  •  Mechanism of docetaxel and cabazitaxel-resistance in castration-resistant prostate cancer

    • Principal Investigator
      KADONO Yoshifumi
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kanazawa University
  •  Elucidation of mechanisms of the prostate cancer progress in consideration of AR Axis / microenvironment and the construction of the innovative treatment strategy

    • Principal Investigator
      NAMIKI Mikio
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kanazawa University
  •  The mechanisms of prostate cancer progression in bone metastasis microenvironment through CCL2 signaling

    • Principal Investigator
      NARIMOTO Kazutaka
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kanazawa University
  •  Prevention of CRPC and application for docetaxel treatment using flavonoids

    • Principal Investigator
      MIZOKAMI Atsushi
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kanazawa University
  •  Exploration of gene impairments assosiated with non-coding DNA, which involves in an Alu sequences causing male infertility

    • Principal Investigator
      NAMIKI Mikio
    • Project Period (FY)
      2013 – 2014
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Urology
    • Research Institution
      Kanazawa University
  •  The mechanism of prostate cancer progression via the macrophage infiltration into prostate cancer microenvironmentPrincipal Investigator

    • Principal Investigator
      IZUMI Kouji
    • Project Period (FY)
      2013 – 2014
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Urology
    • Research Institution
      Kanazawa University

All 2021 2020 2019 2018 2016 2015 2014 2013

All Journal Article Presentation

  • [Journal Article] Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy2021

    • Author(s)
      Iwamoto H, Kano H, Shimada T, Naito R, Makino T, Kadomoto S, Yaegashi H, Shigehara K, Izumi K, Kadono Y, Mizokami A.
    • Journal Title

      In Vivo

      Volume: 35 Pages: 1703-1709

    • DOI

      10.21873/invivo.12430

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09685, KAKENHI-PROJECT-21K16728
  • [Journal Article] Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment.2021

    • Author(s)
      Makino T, Izumi K, Mizokami A.
    • Journal Title

      Biomedicines

      Volume: 9 Pages: 414-414

    • DOI

      10.3390/biomedicines9040414

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09685
  • [Journal Article] Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cells.2021

    • Author(s)
      Makino T, Izumi K, Hiratsuka K, Kano H, Shimada T, Nakano T, Kadomoto S, Naito R, Iwamoto H, Yaegashi H, Shigehara K, Kadono Y, Nakata H, Saito Y, Nakagawa-Goto K, Sakai N, Iwata Y, Wada T, Mizokami A.
    • Journal Title

      Scientific reports

      Volume: 11 Pages: 675-675

    • DOI

      10.1038/s41598-020-80302-4

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08426, KAKENHI-PROJECT-19K09685, KAKENHI-PROJECT-20K09574
  • [Journal Article] Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells.2019

    • Author(s)
      Iwamoto H, Izumi K*, Natsagdorj A, Naito R, Makino T, Kadomoto S, Hiratsuka K, Shigehara K, Kadono Y, Narimoto K, Saito Y, Nakagawa-Goto K, Mizokami A.
    • Journal Title

      Prostate

      Volume: 79 Pages: 468-479

    • DOI

      10.1002/pros.23753

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K11126
  • [Journal Article] C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment.2018

    • Author(s)
      Urata S, Izumi K, Hiratsuka K, Maolake A, Natsagdorj A, Shigehara K, Iwamoto H, Kadomoto S, Makino T, Naito R, Kadono Y, Lin WJ, Wufuer G, Narimoto K, Mizokami A
    • Journal Title

      Cancer Science

      Volume: 109 Pages: 724-731

    • DOI

      10.1111/cas.13494

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11126
  • [Journal Article] Crosstalk Between Androgen-Sensitive and Androgen-Insensitive Prostate Cancer Cells2018

    • Author(s)
      YUTA TAKEZAWA, KOUJI IZUMI, KAZUAKI MACHIOKA, HIROAKI IWAMOTO, RENATO NAITO, TOMOYUKI MAKINO, SUGURU KADOMOTO, ARIUNBOLD NATSAGDORJ, YOSHIFUMI KADONO, EVAN T. KELLER, JIAN ZHANG and ATSUSHI MIZOKAMI
    • Journal Title

      Anticancer Research

      Volume: 38 Pages: 2045-2055

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17H04325
  • [Journal Article] Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines2018

    • Author(s)
      Kazuaki Machioka, 1Kouji Izumi, 1Yoshifumi Kadono, 1Hiroaki Iwamoto, 1Renato Naito, 1Tomoyuki Makino, 1Suguru Kadomoto, 1Ariunbold Natsagdorj, 2Evan T. Keller, 3Jian Zhang, and 1Atsushi Mizokami
    • Journal Title

      Oncotarget

      Volume: 9 Pages: 16185-16196

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17H04325
  • [Journal Article] Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation.2018

    • Author(s)
      Maolake A, Izumi K, Natsagdorj A, Iwamoto H, Kadomoto S, Makino T, Naito R, Shigehara K, Kadono Y, Hiratsuka K, Wufuer G, Nastiuk KL, Mizokami A.
    • Journal Title

      Cancer science

      Volume: 109 Pages: 1524-1531

    • DOI

      10.1111/cas.13586

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K11128, KAKENHI-PROJECT-16K10998
  • [Journal Article] Crosstalk Between Androgen-sensitive and Androgen-insensitive Prostate Cancer Cells.2018

    • Author(s)
      Takezawa Y, Izumi K, Machioka K, Iwamoto H, Naito R, Makino T, Kadomoto S, Natsagdorj A, Kadono Y, Keller ET, Zhang J, Mizokami A.
    • Journal Title

      Anticancer research

      Volume: 38 Pages: 2045-2055

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17H04325
  • [Journal Article] Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines2018

    • Author(s)
      Machioka K, Izumi K, Kadono Y, Iwamoto H, Naito R, Makino T, Kadomoto S, Natsagdorj A, Keller ET, Zhang J, Mizokami A
    • Journal Title

      Oncotarget

      Volume: 9 Pages: 16185-16196

    • DOI

      10.18632/oncotarget.24609

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17H04325, KAKENHI-PROJECT-16K10999
  • [Journal Article] Active Estrogen Synthesis and its Function in Prostate Cancer-derived Stromal Cells2015

    • Author(s)
      K. Machioka, A. Mizokami, Y. Yamaguchi, K. Izumi, S. Hayashi and M. Namiki
    • Journal Title

      Anticancer Res

      Volume: 35 Pages: 221-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26293350
  • [Journal Article] SOD3 acts as a tumor suppressor in PC-3 prostate cancer cells via hydrogen peroxide accumulation.2014

    • Author(s)
      J. Kim, A. Mizokami, M. Shin, K. Izumi, H. Konaka, Y. Kadono, Y. Kitagawa, E. T. Keller, J. Zhang and M. Namiki
    • Journal Title

      Anticancer Res

      Volume: 34 Pages: 2821-31

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26293350
  • [Journal Article] Repression of cell proliferation and androgen receptor activity in prostate cancer cells by 2'-hydroxyflavanone2013

    • Author(s)
      M. Ofude, A. Mizokami, M. Kumaki, K. Izumi, H. Konaka, Y. Kadono, Y. Kitagawa, M. Shin, J. Zhang, E. T. Keller and M. Namiki
    • Journal Title

      Anticancer Research

      Volume: 10 Pages: 4453-61

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25462472
  • [Journal Article] Targeting the androgen receptor promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.2013

    • Author(s)
      15. Izumi K, Fang LY, Mizokami A, Namiki M, Li L, Lin WJ, Chang C
    • Journal Title

      EMBO Mol Med

      Volume: 5 Pages: 1383-1401

    • DOI

      10.1002/emmm.201202367

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25861413
  • [Presentation] コーヒージテルペンkahweol acetateとcafestolのヒト腎細胞癌細胞に対する増殖・遊走抑制効果2021

    • Author(s)
      牧野友幸、泉浩二、岩本大旭、加納洋、島田貴史、門本卓、内藤伶奈人、八重樫洋、角野佳史、溝上敦
    • Organizer
      第109回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-19K09685
  • [Presentation] CCL2-CCR2はアンドロゲン非依存性前立腺癌細胞のカバジタキセル体制に関与する2021

    • Author(s)
      加納洋、泉浩二、Natsagdorj Ariunbold、福田理恵、神島泰樹、島田貴史、内藤伶奈人、牧野友幸、門本卓、岩本大旭、八重樫洋、角野佳史、溝上敦
    • Organizer
      第109回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-21K19558
  • [Presentation] アンドロゲン受容体シグナルの両価性 基礎部門ワークショップ「前立腺癌におけるアンドロゲン受容体研究の最前線」2021

    • Author(s)
      泉浩二
    • Organizer
      第36回前立腺シンポジウム
    • Invited
    • Data Source
      KAKENHI-PROJECT-21K19558
  • [Presentation] コーヒージテルペンkahweol acetateとcafestolのヒト腎細胞癌細胞に対する増殖・遊走抑制効果2021

    • Author(s)
      牧野友幸、泉浩二、岩本大旭、加納洋、島田貴史、門本卓、内藤伶奈人、八重樫洋、角野佳史、溝上敦
    • Organizer
      第109回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-20K09574
  • [Presentation] コーヒージテルペン酢酸カーウェオールとカフェストールのヒト腎癌細胞における抗腫瘍効果についての検討2021

    • Author(s)
      牧野友幸、泉浩二、岩本大旭、加納洋、島田貴史、門本卓、内藤伶奈人、八重樫洋、角野佳史、溝上敦
    • Organizer
      第71回日本泌尿器科学会中部総会
    • Data Source
      KAKENHI-PROJECT-20K09574
  • [Presentation] コーヒージテルペンKahweol acetateとcafestolは腎細胞癌の増殖・遊走を抑制する2021

    • Author(s)
      牧野友幸、泉浩二、岩本大旭、加納洋、島田貴史、門本卓、内藤伶奈人、八重樫洋、角野佳史、溝上敦
    • Organizer
      第30回泌尿器科分子・細胞研究会
    • Data Source
      KAKENHI-PROJECT-20K09574
  • [Presentation] 新規アンドロゲン受容体シグナル伝達阻害薬とタキサン系抗癌剤は去勢抵抗性前立腺癌の内臓転移を誘発する2021

    • Author(s)
      岩本大旭、泉浩二、内藤伶奈人、牧野友幸、門本卓、八重樫洋、角野佳史、溝上敦
    • Organizer
      第30回日本がん転移学会学術集会
    • Data Source
      KAKENHI-PROJECT-21K19558
  • [Presentation] 新規アンドロゲン受容体シグナル伝達阻害薬とタキサン系抗癌剤は去勢抵抗性前立腺癌の内臓転移を誘発する2021

    • Author(s)
      岩本大旭、泉浩二、内藤伶奈人、牧野友幸、門本卓、八重樫洋、角野佳史、溝上敦
    • Organizer
      第30回日本がん転移学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K09685
  • [Presentation] CCL2-CCR2はアンドロゲン非依存性前立腺癌細胞のカバジタキセル体制に関与する2021

    • Author(s)
      加納洋、泉浩二、Natsagdorj Ariunbold、福田理恵、神島泰樹、島田貴史、内藤伶奈人、牧野友幸、門本卓、岩本大旭、八重樫洋、角野佳史、溝上敦
    • Organizer
      第109回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-19K09685
  • [Presentation] Anticancer effects of coffee diterpenes kahweol acetate and cafectol on prostate cancer2021

    • Author(s)
      Hiroaki Iwamoto, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
    • Organizer
      第79回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-21K19558
  • [Presentation] コーヒージテルペン酢酸カーウェオールとカフェストールのヒト腎癌細胞における抗腫瘍効果についての検討2021

    • Author(s)
      牧野友幸、泉浩二、岩本大旭、加納洋、島田貴史、門本卓、内藤伶奈人、八重樫洋、角野佳史、溝上敦
    • Organizer
      第71回日本泌尿器科学会中部総会
    • Data Source
      KAKENHI-PROJECT-19K09685
  • [Presentation] アンドロゲン受容体シグナルの両価性2021

    • Author(s)
      泉 浩二
    • Organizer
      第36回前立腺シンポジウム
    • Invited
    • Data Source
      KAKENHI-PROJECT-19K09685
  • [Presentation] コーヒージテルペンであるカーウェオールアセテートtpカフェストールは前立腺癌細胞の増殖と遊走を相乗的に阻害する2020

    • Author(s)
      岩本大旭、泉浩二、門本卓、内藤伶奈人、牧野友幸、八重樫洋、飯島将司、川口昌平、野原隆弘、重原一慶、角野佳史、溝上敦
    • Organizer
      第108回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-19K09685
  • [Presentation] 新規アンドロゲン受容体シグナル伝達阻害薬とタキサン系抗癌剤は去勢抵抗性前立腺癌の内臓転移を誘発する2020

    • Author(s)
      岩本大旭、泉浩二、門本卓、八重樫洋、飯島将司、川口昌平、野原隆弘、重原一慶、角野佳史、溝上敦
    • Organizer
      第70回日本泌尿器科学会中部総会
    • Data Source
      KAKENHI-PROJECT-19K09707
  • [Presentation] コーヒージテルペンKahweol acetateとcafestolは腎細胞癌の増殖・遊走を抑制する2020

    • Author(s)
      牧野友幸、泉浩二、岩本大旭、加納洋、島田貴史、門本卓、内藤伶奈人、八重樫洋、角野佳史、溝上敦
    • Organizer
      第108回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-19K09685
  • [Presentation] コーヒージテルペンであるkahweol acetateとcafestolは相乗作用で前立腺癌細胞の増殖と遊走を阻害する2019

    • Author(s)
      岩本大旭、泉浩二、ナッサグドルジアリウンボルト、門本卓、内藤伶奈人、牧野友幸、角野佳史、溝上敦
    • Organizer
      第107回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-19K09685
  • [Presentation] アンドロゲン感受性前立腺癌細胞と非感受性前立腺癌細胞のクロストーク2016

    • Author(s)
      武澤 雄太 、溝上 敦 、泉 浩二 、並木 幹夫
    • Organizer
      日本癌学会
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-26293350
  • [Presentation] Crosstalk of androgen sensitive prostate cancer cells and insensitive prostate cancer cells2016

    • Author(s)
      Takezawa Yuta, Mizokami Atsushi, Machioka Kazuaki, Izumi Kouji, Iwamoto Hiroaki, Aerken Maolake, Ariunbold Natsagdorj, and Namiki Mikio
    • Organizer
      AACR Annual Meeting 2016
    • Place of Presentation
      New Orleans, USA
    • Year and Date
      2016-04-16
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26293350
  • 1.  MIZOKAMI Atsushi (50248580)
    # of Collaborated Projects: 12 results
    # of Collaborated Products: 29 results
  • 2.  NARIMOTO Kazutaka (50645207)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 2 results
  • 3.  KADONO Yoshifumi (10397218)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 6 results
  • 4.  KONAKA Hiroyuki (40334768)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 1 results
  • 5.  NAMIKI Mikio (70155985)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 4 results
  • 6.  NOHARA Takahiro (20733372)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 1 results
  • 7.  後藤 享子 (50180245)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 8.  KOH Eitetsu (90283134)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  北川 育秀 (00452102)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 10.  岩本 大旭 (90847245)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 11.  IWATA Yasunori
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 12.  中川 享子
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to connect your ORCID iD to this researcher?
* This action can be performed only by the researcher themselves.

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi